This is the authors' abstract. We don't add key points for this paper.
This case report shows pseudoprogression with a subsequent good response to neoadjuvant anti–PD-1 therapy in ocular surface squamous neoplasia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Desforges et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: